
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14864573
[patent_doc_number] => 20190282528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => NOVEL REVERSIBLE NITROXIDE DERIVATIVES OF NITROALKENES THAT MEDIATE NITROSATING AND ALKYLATING REACTIONS
[patent_app_type] => utility
[patent_app_number] => 16/339703
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339703
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339703 | Reversible nitroxide derivatives of nitroalkenes that mediate nitrosating and alkylating reactions | Oct 3, 2017 | Issued |
Array
(
[id] => 16137771
[patent_doc_number] => 10701935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Method for controlling rust
[patent_app_type] => utility
[patent_app_number] => 15/721175
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6953
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721175
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721175 | Method for controlling rust | Sep 28, 2017 | Issued |
Array
(
[id] => 14926155
[patent_doc_number] => 20190298715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY
[patent_app_type] => utility
[patent_app_number] => 16/338085
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338085
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338085 | IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY | Sep 28, 2017 | Abandoned |
Array
(
[id] => 13035299
[patent_doc_number] => 10039762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Inhibitors of influenza viruses replication
[patent_app_type] => utility
[patent_app_number] => 15/718186
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 115
[patent_figures_cnt] => 116
[patent_no_of_words] => 140962
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15718186
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/718186 | Inhibitors of influenza viruses replication | Sep 27, 2017 | Issued |
Array
(
[id] => 12124992
[patent_doc_number] => 20180008578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'USE OF PROSTACYCLIN ANTAGONISTS FOR TREATING OCULAR SURFACE NOCICEPTION'
[patent_app_type] => utility
[patent_app_number] => 15/710438
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11326
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710438
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/710438 | USE OF PROSTACYCLIN ANTAGONISTS FOR TREATING OCULAR SURFACE NOCICEPTION | Sep 19, 2017 | Abandoned |
Array
(
[id] => 12117244
[patent_doc_number] => 20180000830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'INHIBITORS OF HEMOPOIETIC CELL KINASE (P-59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/706152
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 50472
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15706152
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/706152 | INHIBITORS OF HEMOPOIETIC CELL KINASE (P-59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION | Sep 14, 2017 | Abandoned |
Array
(
[id] => 15946213
[patent_doc_number] => 10660985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Kits, compositions and methods for wound treatment and management
[patent_app_type] => utility
[patent_app_number] => 15/703262
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 10685
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703262
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703262 | Kits, compositions and methods for wound treatment and management | Sep 12, 2017 | Issued |
Array
(
[id] => 12238325
[patent_doc_number] => 20180071187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'INHIBITION OF MELANOGENESIS BY CHEMICALLY MODIFIED CURCUMINS'
[patent_app_type] => utility
[patent_app_number] => 15/702122
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22114
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15702122
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/702122 | Inhibition of melanogenesis by chemically modified curcumins | Sep 11, 2017 | Issued |
Array
(
[id] => 17110013
[patent_doc_number] => 20210290610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => COMBINATION OF FXR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/332446
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332446
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332446 | COMBINATION OF FXR AGONISTS | Sep 11, 2017 | Abandoned |
Array
(
[id] => 12183969
[patent_doc_number] => 20180042905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'METHODS OF TREATING HEPATITIS B VIRUS'
[patent_app_type] => utility
[patent_app_number] => 15/689985
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32780
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15689985
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/689985 | METHODS OF TREATING HEPATITIS B VIRUS | Aug 28, 2017 | Abandoned |
Array
(
[id] => 12217483
[patent_doc_number] => 20180055842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'Combination Therapy with Glutaminase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/685566
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18093
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685566
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/685566 | Combination therapy with glutaminase inhibitors | Aug 23, 2017 | Issued |
Array
(
[id] => 14864577
[patent_doc_number] => 20190282530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => ALL-TRANS RETINOIC ACID INJECTANT AND APPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/326216
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326216
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326216 | All-trans retinoic acid injectant and application | Aug 16, 2017 | Issued |
Array
(
[id] => 14945587
[patent_doc_number] => 10434038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-08
[patent_title] => Solid phosphonate salts as an add-on in endodontics
[patent_app_type] => utility
[patent_app_number] => 15/677713
[patent_app_country] => US
[patent_app_date] => 2017-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 5649
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15677713
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/677713 | Solid phosphonate salts as an add-on in endodontics | Aug 14, 2017 | Issued |
Array
(
[id] => 15694325
[patent_doc_number] => 10603323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/320949
[patent_app_country] => US
[patent_app_date] => 2017-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 7168
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320949
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320949 | Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors | Aug 13, 2017 | Issued |
Array
(
[id] => 12205786
[patent_doc_number] => 20180051012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/674914
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26525
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674914
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674914 | Diacylglycerol acyl transferase 2 inhibitors | Aug 10, 2017 | Issued |
Array
(
[id] => 16108347
[patent_doc_number] => 20200206196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => Antiviral Drugs
[patent_app_type] => utility
[patent_app_number] => 16/622035
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622035
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622035 | Antiviral Drugs | Aug 10, 2017 | Abandoned |
Array
(
[id] => 12056292
[patent_doc_number] => 20170332636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'METHOD FOR CONTROLLING RUST'
[patent_app_type] => utility
[patent_app_number] => 15/673311
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7065
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673311 | Method for controlling rust | Aug 8, 2017 | Issued |
Array
(
[id] => 12056294
[patent_doc_number] => 20170332638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'METHOD FOR CONTROLLING RUST'
[patent_app_type] => utility
[patent_app_number] => 15/673316
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7065
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673316
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673316 | Method for controlling rust | Aug 8, 2017 | Issued |
Array
(
[id] => 14636117
[patent_doc_number] => 10362782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => Method for controlling rust
[patent_app_type] => utility
[patent_app_number] => 15/673313
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6908
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673313
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673313 | Method for controlling rust | Aug 8, 2017 | Issued |
Array
(
[id] => 12057115
[patent_doc_number] => 20170333459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'METHODS OF TREATING ORTHOPOX VIRUS INFECTIONS AND ASSOCIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/669084
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13045
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15669084
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/669084 | METHODS OF TREATING ORTHOPOX VIRUS INFECTIONS AND ASSOCIATED DISEASES | Aug 3, 2017 | Abandoned |